Skip to content

Author

Xia Li

We have 3 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Dihydrotanshinone I suppresses ovarian cancer by targeting splicing factor SRSF1 to regulate the long non-coding RNA SLC8A1-AS1/FOXO1 axis.

BACKGROUND Ovarian cancer (OC) is a lethal malignancy with limited therapies. The natural compound dihydrotanshinone I (DHT) exhibits broad antitumor activity, yet its precise molecular targets and mechanistic interplay with oncogenic lncRNAs in OC remain largely unexplored. PURPOSE This study aimed to investigate th...

Xin-Ming Tu, Rui-Wen Yang, Cheng-Yu Miao et al. · 0 citations
Open access Sep 2026

NSUN2‐Mediated m5C Modification of TGFB1 in Trophoblasts Remodels Macrophage Function to Prevent URSA

ABSTRACT Unexplained Recurrent Spontaneous Abortion (URSA) is a prevalent early pregnancy disorder with substantial implications for reproductive health, yet its pathogenesis remains poorly understood. Here, we uncover a previously unrecognized role of NOP2/Sun RNA methyltransferase 2 (NSUN2), an RNA 5‐methylcytosine (...

Xiaoxiao Zhu, Xin-Kui Liu, Xiao-Yan Yu et al. · 0 citations
Editorial 2016

Arteriosclerosis, Thrombosis, and Vascular Biology

This proof-of-concept study suggests the potent low-hemorrhage antithrombotic effect of MK by targeting FXIa and unveiling a new therapeutic application of MK.

Arterioscler Thromb, Vasc Biol, Ming-Dong Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.